LIVE
PG
The Procter & Gamble Company · Consumer Staples
$150.38
+6.43% this month
VERSUS
⟷
COMPARE
CL
Colgate-Palmolive Company · Consumer Staples
$89.48
-0.60% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
PG
4
CL
1
Comparison scoreboard
PG LEADS 4/5AI Score
PG ✓40.8
CL 40.5
1Y Return
PG -5.13%
CL ✓+0.96%
Fwd P/E
PG ✓21.11
CL 22.13
Target Up.
PG ✓+9.24%
CL +7.15%
Op. Margin
PG ✓23.05%
CL 20.92%
Metrics last refreshed: 6/20/2026
Quick take
PG vs CL Stock Comparison: AI Score, Valuation, Performance and Upside
Procter & Gamble and Colgate-Palmolive are two of the most iconic consumer staples companies, both known for dominant global brands, consistent dividend growth, and pricing power. P&G is the larger, more diversified portfolio company; Colgate is more concentrated in oral care and pet nutrition with a heavier developing market exposure. Both are high-quality dividend compounders, but P&G's scale and portfolio breadth give it slightly more defensive characteristics.
P&G is the larger, more defensive consumer staples compounder with unmatched pricing power across a diversified category portfolio; Colgate offers higher developing market growth exposure and Hill's pet nutrition as an additional compounding engine.
Live analysis · updated 6/20/2026
PG holds the edge across 4 of 5 key metrics in this comparison. CL has delivered stronger 1-year price return (+0.96% vs -5.13%), though PG trades at the lower forward P/E (21.11x vs 22.13x). On fundamentals, CL is growing revenue faster (8.40%), while PG maintains the higher operating margin (23.05%) — a classic growth-versus-profitability split. Analyst consensus implies similar upside for both: +9.24% for PG and +7.15% for CL.
Normalized 1Y performance
PG
CL
Recent returns
PG
CL
Analyst price targets & sentiment
PG · 23 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.0/5.0)
Price target range
analyst low$140.00
analyst high$190.00
analyst mean$163.43
current price$150.38
+9.2% upside to analyst mean
CL
Price target range
analyst mean$95.85
current price$89.48
+7.2% upside to analyst mean
Who should consider this stock?
PG may suit investors who:
- →want the broadest consumer staples portfolio with pricing power across 65 global brand categories
- →prioritize dividend Dividend King status with 67+ consecutive annual increases
- →prefer more US revenue exposure versus Colgate's higher emerging market concentration
- →value the sheer scale advantage enabling R&D and marketing investment that smaller peers cannot match
CL may suit investors who:
- →want concentrated exposure to global oral care — a category with secular demand from hygiene awareness
- →value Hill's pet nutrition as an accelerating high-margin growth engine within the portfolio
- →believe emerging market consumer spending will drive above-market organic revenue growth long-term
- →are comfortable with higher FX exposure in exchange for developing world growth leverage
Performance & AI score
| Metric | PG | CL |
|---|---|---|
| AI score | 40.8 | 40.5 |
| AI rank | #1013 | #1043 |
| Latest close | $150.38 | $89.48 |
| 1M return | +6.43% | -0.60% |
| 6M return | +1.74% | +12.23% |
| 1Y return | -5.13% | +0.96% |
$10,000 invested — hypothetical growth (dividends reinvested)
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | PG | CL |
|---|---|---|
| 1Y ago | $9.52K (-4.8%) started 2025-06-18 | $10.15K (+1.5%) started 2025-06-18 |
| 5Y ago | $13.84K (+38.4%) started 2021-06-21 | $13.31K (+33.1%) started 2021-06-21 |
| 10Y ago | $30.5K (+205.0%) started 2016-06-20 | $19.47K (+94.7%) started 2016-06-20 |
Hypothetical — past performance does not guarantee future results.
Valuation & upside potential
| Metric | PG | CL |
|---|---|---|
| Market cap | $348.38B | $71.58B |
| Trailing P/E | 21.87 | 34.67 |
| Forward P/E | 21.11 | 22.13 |
| Price/Sales | 4.58 | N/A |
| EV/Revenue | 4.31 | 3.77 |
| Analyst target | $163.43 | $95.85 |
| Target upside | +9.24% | +7.15% |
Growth, profitability & risk
| Metric | PG | CL |
|---|---|---|
| Revenue growth | 7.40% | 8.40% |
| Earnings growth | 5.80% | -5.90% |
| EPS growth | +5.80% | -5.90% |
| FCF margin | +14.68% | +15.96% |
| Operating margin | 23.05% | 20.92% |
| Profit margin | 19.16% | 10.04% |
| ROIC proxy | 31.11% | 363.58% |
| Return on equity | 31.11% | 363.58% |
| Dividend yield | 2.85% | 2.37% |
| Beta | 0.39 | 0.32 |
| Debt/equity | 67.65 | 1640.54 |
| Current ratio | 0.73 | 1.02 |
| Quick ratio | 0.49 | 0.56 |
Drawdown & downside risk
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
1Y risk snapshot
PG max drawdown16.15%
CL max drawdown19.66%
PG max wkly drop8.12%
CL max wkly drop7.16%
5Y risk snapshot
PG max drawdown23.77%
CL max drawdown29.94%
PG max wkly drop8.92%
CL max wkly drop8.10%
10Y risk snapshot
PG max drawdown23.77%
CL max drawdown29.94%
PG max wkly drop16.27%
CL max wkly drop12.85%
Performance metrics by period
| Period | Metric | PG | CL |
|---|---|---|---|
| 1Y | Growth | -4.83% | +1.46% |
| CAGR | -4.84% | +1.46% | |
| Sharpe ratio | -0.42 | -0.03 | |
| Max drawdown | 16.15% | 19.66% | |
| Max daily drop | 3.56% | 3.85% | |
| Max wkly drop | 8.12% | 7.16% | |
| 5Y | Growth | +24.76% | +20.69% |
| CAGR | +4.53% | +3.84% | |
| Sharpe ratio | 0.09 | 0.06 | |
| Max drawdown | 23.77% | 29.94% | |
| Max daily drop | 6.23% | 5.22% | |
| Max wkly drop | 8.92% | 8.10% | |
| 10Y | Growth | +131.23% | +54.18% |
| CAGR | +8.75% | +4.43% | |
| Sharpe ratio | 0.30 | 0.09 | |
| Max drawdown | 23.77% | 29.94% | |
| Max daily drop | 8.74% | 9.78% | |
| Max wkly drop | 16.27% | 12.85% |
Business comparison
| Category | PG | CL |
|---|---|---|
| Company | The Procter & Gamble Company | Colgate-Palmolive Company |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Household & Personal Products | N/A |
| Core business | Procter & Gamble is the world's largest consumer products company, with a portfolio of 65 brands spanning baby care, fabric care, feminine care, home care, hair care, personal care, and grooming. Its brand portfolio includes Tide, Pampers, Gillette, Always, and Head & Shoulders — each #1 or #2 in their respective global categories. P&G's strategy centers on premium-tier innovation within each category and consistent price increases ahead of commodity cost inflation. | Colgate-Palmolive is a global consumer products company best known for its Colgate oral care brand — the world's leading toothpaste — plus Hill's pet nutrition, household products (Palmolive), and personal care. Oral care accounts for approximately 40% of revenue, and Colgate has commanding 40%+ global market share in toothpaste in many regions. Hill's pet nutrition is its highest-growth segment, benefiting from the premiumization of pet care globally. |
| Investor focus | Investors track organic revenue growth (volume plus pricing), gross margin recovery after years of commodity headwinds, emerging market penetration especially in Asia and Africa, and dividend growth — P&G has increased its dividend for 67+ consecutive years (Dividend King). | Investors track Colgate's oral care market share globally (key brand health indicator), Hill's pet nutrition growth rates, gross margin recovery, and organic revenue growth versus pricing/volume split. Colgate's emerging market revenue concentration (50%+ of sales) is both a growth driver and FX risk. |
PG strengths
- →Portfolio of dominant global brands with #1 or #2 share in most categories
- →Proven ability to take consistent price increases while maintaining market share — a true pricing power signal
- →67+ consecutive years of dividend increases — one of the longest streaks of any S&P 500 company
CL strengths
- →World's leading toothpaste brand with commanding market share in developing markets
- →Hill's pet nutrition is a high-growth, premium category with durable consumer trends
- →Extensive emerging market distribution infrastructure provides revenue in high-growth geographies
Risks to watch — PG
- →Volume elasticity — prolonged price increases eventually slow unit volume as consumers trade down
- →Private label competition intensifying, particularly in fabric care and paper products
- →Emerging market exposure creates FX headwinds as local currencies weaken versus the dollar
Risks to watch — CL
- →50%+ revenue from emerging markets creates significant FX translation headwinds
- →Oral care category can face private label competition in value-sensitive markets
- →Hill's voluntary recalls (2019-2020) created reputation risk in the high-margin pet segment
Frequently asked questions
Free public comparison
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Related comparisons
More comparisons
Browse all 1,000 comparisons →